Testing effectiveness (Phase 2)Ended earlyNCT04579679
What this trial is testing
Open-Label Surufatinib in European Patients With NET
Who this might be right for
Neuroendocrine TumoursNeuroendocrine Tumour of the LungSmall Intestinal NET
Hutchmed 78